| abstract |
The invention relates to novel products of formula (I): with R1 represents alkyl, cycloalkyl or cycloalkylalkyl; Rb represents a hydrogen atom or a fluorine atom W represents H; alkyl, cycloalkyl, heterocycloalkyl or COR with R represents cycloalkyl, heterocycloalkyl, alkyl; alkoxy, -O-heterocycloalkyl; or NHR2 with R2 is H, cycloalkyl, heterocycloalkyl or alkyl; all possibly substituted; these products being in all isomeric forms and salts, as medicaments especially as MET inhibitors. |